Skip to content

Lifeline Endocardial Unipolar Lead 483-08

by Intermedics, Inc.

510(k) K853517

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK853517 Date4 Dec 1985ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Lifeline Endocardial Unipolar Lead 483-08 is a Permanent Pacemaker Electrode, designed for endocardial implantation to deliver electrical stimulation to the heart. This unipolar lead facilitates cardiac pacing by transmitting electrical impulses to the endocardium, ensuring proper heart rhythm regulation in patients requiring pacemaker therapy.

This lead is supplied sterile and intended for single-use implantation within a cardiac electrophysiology setting. It is classified as a Class III device under FDA regulations and has received FDA 510K clearance as substantially equivalent to a predicate device. The lead is compatible with MRI environments under specific conditions, as outlined in its labeling, and is available in a single model number (483-08) for endocardial pacing applications.

Other devices from Intermedics, Inc.

See all devices from Intermedics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Is this lead reusable or intended for single-use only, and how does that affect its handling in a clinical setting?

    The Lifeline Endocardial Unipolar Lead 483-08 is explicitly designed for single-use implantation and is supplied sterile. This means it must not be reused after one procedure to maintain patient safety and sterility. Clinicians should follow standard sterile field protocols during implantation, as the lead is not intended for reprocessing or reuse.

  • What are the key considerations for storage of this device before implantation?

    Since the lead is supplied sterile, it should be stored in its original packaging until ready for use to preserve sterility. The packaging is likely sealed and designed to protect the device from contamination. Always check the manufacturer’s labeling for specific storage conditions, such as temperature or humidity restrictions, though none are explicitly mentioned in the provided data.

  • Does this lead come in multiple sizes or models, or is there only one version available?

    The Lifeline Endocardial Unipolar Lead 483-08 is available only in a single model number (483-08). This model is designed specifically for endocardial pacing applications, meaning it is not interchangeable with other lead types or sizes unless explicitly stated by the manufacturer. Always verify compatibility with the pacemaker system being used.

  • What regulatory pathway was followed for FDA clearance, and what does that mean for clinicians?

    The lead received FDA 510(k) clearance under the Traditional Review pathway, determined to be substantially equivalent to a predicate device. This means the FDA reviewed it against an existing approved lead and confirmed it meets safety and effectiveness standards for permanent pacemaker electrode use. Clinicians can rely on this clearance as evidence of regulatory scrutiny, though they should always refer to the device’s labeling for specific instructions.